Literature DB >> 21498153

Profile of HIV/AIDS patients in a tertiary hospital in Istanbul, Turkey.

Hayat Kumbasar Karaosmanoglu1, Ozlem Altuntas Aydin, Ozcan Nazlican.   

Abstract

BACKGROUND: In Turkey, the first HIV/AIDS case was reported in 1985. Although HIV/AIDS incidence has been increasing, only 3,671 cases have been documented to date in this country, with a population of 71,517,100. The aim of this study was to determine the epidemiologic and clinical features of patients with HIV infection and AIDS followed during a 3.5-year period.
METHODS: A total of 136 HIV-infected patients attending Infectious Diseases and Clinical Microbiology Outpatient Clinic of Haseki Training and Research Hospital between January 2006 and June 2009 were included in the study. Epidemiologic and clinical data, such as age, gender, marital status, occupation, level of education, transmission routes, condom usage, type of screening tests, clinical findings, and CD4 T-cell counts and viral loads at diagnosis, were collected retrospectively from case records completed on admission.
RESULTS: Patients with a diagnosis of HIV infection comprised a group of 136 persons (80% men, mean age 36 years [range, 20-72 years]). Six patients (8%) were university graduates. Heterosexual intercourse was the most common route of transmission (60%), followed by homosexual intercourse and intravenous drug use. Almost all women (24 out of 25; 96%) acquired the infection from their husbands. Median CD4 T-cell count at diagnosis was 302/mm3 (range, 9-1,270). On admission, CD4 T-cell count was < 200/mm3 in 39%, 200-350/mm3 in 30%, and ≯350/mL in 31%. Mean viral load at diagnosis was 1,033,871 copies/mL. Forty-four percent of the patients were admitted with obvious clinical signs and symptoms, whereas 56% were diagnosed through screening tests.
CONCLUSIONS: Poorly educated individuals and men constituted the majority of the cases. Most women acquired the disease from their husbands. Considering the poor level of education among the patients we studied, effective educational programs should be developed to reduce the transmission of HIV. Although heterosexual intercourse was the most common route of transmission, 38% of the patients we studied reported male-to-male intercourse. This is markedly higher than the 9% rate of transmission by this route in Turkey.

Entities:  

Mesh:

Year:  2011        PMID: 21498153     DOI: 10.1310/hct1202-104

Source DB:  PubMed          Journal:  HIV Clin Trials        ISSN: 1528-4336


  6 in total

1.  Clinico-Epidemiological Analysis of HIV/AIDS Patients.

Authors:  Baris Ertunc; Selcuk Kaya; Iftihar Koksal
Journal:  Eurasian J Med       Date:  2016-10

2.  Molecular epidemiology of HIV in a cohort of men having sex with men from Istanbul.

Authors:  Dilek Alpsar; Ali Agacfidan; Nadine Lübke; Jens Verheyen; Haluk Eraksoy; Atahan Cağatay; Emel Bozkaya; Rolf Kaiser; Baki Akgül
Journal:  Med Microbiol Immunol       Date:  2013-01-08       Impact factor: 3.402

3.  Lived experiences of people living with HIV: a descriptive qualitative analysis of their perceptions of themselves, their social spheres, healthcare professionals and the challenges they face daily.

Authors:  Gamze Senyurek; Mustafa Volkan Kavas; Yesim Isil Ulman
Journal:  BMC Public Health       Date:  2021-05-12       Impact factor: 3.295

4.  Low Prevalence of Hepatitis C Virus Infection Among HIV-Positive Patients: Data From a Large-Scale Cohort Study in Istanbul, Turkey.

Authors:  Ozlem Altuntas Aydin; Mucahit Yemisen; Hayat Kumbasar Karaosmanoglu; Fatma Sargin; Alper Gunduz; Bahadir Ceylan; Bilgul Mete; Nail Ozgunes; Dilek Yildiz Sevgi; Resat Ozaras; Fehmi Tabak
Journal:  Hepat Mon       Date:  2014-08-16       Impact factor: 0.660

5.  Sexual and reproductive health of women living with HIV in Muslim-majority countries: a systematic mixed studies review.

Authors:  Dyah Juliastuti; Judith Dean; Lisa Fitzgerald
Journal:  BMC Int Health Hum Rights       Date:  2020-03-11

6.  AIDS-related deaths in Turkey between 2009 and 2018.

Authors:  Ayse Gulsen Teker
Journal:  Epidemiol Infect       Date:  2021-07-02       Impact factor: 4.434

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.